Kona, Hawaii. For individuals suffering from many types of addiction including drugs, alcohol, sex and gambling, Hawaii Island Recovery has opened its doors. Located in a beautiful surreal location 3000 miles from anywhere, Hawaii Island Recovery boasts many top amenities including luxury villas, full service gym and spa treatments, meals from a gourmet chef and many amazing excursions.

Addiction recovery is a seriously individual, distinctive method of transforming one’s perceptions, beliefs, emotions, objectives, abilities and/or roles. It is a method of experiencing a gratifying, optimistic and contributing life irrespective of your past. Addiction recovery entails the growth of new meaning and purpose in an individual’s life as one evolves outside of the typically devastating outcomes of addiction. Addiction can easily take away so much of your life. Recovery provides you with an opportunity to get it back.

Hawaii Island Recovery offers a luxury rehab program where clients reside in luxurious surroundings while engaged in a serious recovery program. Rejuvenate mind, body and spirit while experiencing wonderful Hawaiian days and nights. Numerous forms of physical exercise, massage and yoga are available to deal with your physical recovery. Individualized recovery with focus on individual requirements encourages the ability to address each specific contributing component.

Families are invited and encouraged to attend and be involved in the recovery process. Addressing the complete person allows each individual family member to heal and begin to live again. With less than 20 clients in residence, each individual receives the attention they need and deserve. Sober living with attention to the individual offers hope and an opportunity for personal growth.

Hawaii Island Recovery offers financing options so recovery can be achieved by practically any one in need. Not only do we have business clients who choose Hawaii Island Recovery for our highly coveted executive rehab program we also deals with many individuals across different careers dealing with many different types of addictions. We are here to work with you help you down the path to recovery.

We hope to see you at Hawaii Island Recovery. If you have any questions please call us at 1-866-515-5032 and we will be glad to answer any questions you have.

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

• Needle-free drug delivery

• Other Injectable/Implantable

Unique analysis offers segmentation of this market for:

• Drug Delivery Technology Revenues

• Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

• Detailed Profiles of Key Companies in Implantable/Injectable Delivery

• Brief Round-Up of Smaller Players

• Current Market Size and Forecasts to 2013

• Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments

• Revenue Forecasts

• New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

• Alkermes, Inc.

• ALZA Corp.

• Antares Pharma, Inc.

• Bioject Medical Technologies, Inc.

• CyDex, Inc.

• MGI Pharma, Inc

• Nektar Therapeutics

• Pacira Pharmaceuticals, Inc.

• pSivida

• SurModics, Inc

• Zogenix Corporation

• AP Pharma

• Baxter BioPharma Solutions

• QLT USA, Inc

• Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

For more information, please visit :
http://www.aarkstore.com/reports/Drug-Delivery-Markets-Implantable-Injectable-and-Needle-Free-Delivery-Systems-28096.html
Or email us at [email protected] or call +919272852585

Drug Device Combination – a High Growth Market

Drug-device combination is defined as the combination of drugs and medical devices that can be chemically or physically united or co-packaged as separate, cross labeled products. The commercialization cycle from R&D to product shows the immense potential of the bundled offering. Currently, the market has a potential of US$10.6 billion and has been experiencing a growth of 15% CAGR for the past two years. In the next five years, the market is expected to grow at a CAGR of 11.8%. A future view of the drug-device combination is that these products will make single component medical devices obsolete.

The drug-eluting stents (DES) market is the largest segment in the drug-device combination market. This is supported by the fact that cardiovascular applications constitute about 64% of the entire drug-device combination applications market. However, it is the relatively smaller market of antimicrobial catheter that offers the highest growth potential over the next five years in the overall market.

The DES market is further segmented into stent grafts, coronary stents and peripheral vascular stents. Though coronary stents has the highest market share, peripheral vascular stents is expected to have the highest growth rate till 2014. The fastest growing macro-market of antimicrobial catheter is segmented into micro-markets such as urological catheter, cardiovascular catheter, peripherally inserted central catheter, oximetry catheter, thermodilution catheter and wound drainage catheter. Closed loop glucose monitor and insulin pump is also expected to record a high growth rate for the period 2009 to 2014. The two major segments: steroid eluting electrodes and photodynamic therapy are estimated to see the slowest growth rate due to a slow development of new products in these markets.

The challenges crippling the growth of the market in the future are expected to be the issues involved in cross industry partnerships, jurisdiction issues, patient safety and interoperability issues.

The drug-device combination market is not fragmented and the key players in this market are Medtronic, Boston Scientific Corp., Edwards Life sciences Corp., Stryker Corp., QLT Inc. etc. The maximum number of new product developments is expected to take place in the bone graft substitutes, advanced wound care products and antimicrobial catheter markets. Our patent analysis indicates that E.U. has filed for the maximum number of patents followed by the U.S.

There is an immense scope of collaboration between the drugs and medical devices companies in the areas of closed loop glucose monitor and insulin pump, bone graft substitutes and advanced wound care products market. However, the antibiotic bone cements and advanced wound care market is expected to face stiff competition in the next five years to come.

The incremental benefits of these combination products over the regular medical devices are increased efficiency, reduction in overall cost of treatment along with the rising awareness. The market holds significant opportunity for the early movers albeit with extensive research to develop new and improved products at competitive prices. Successful strategic alliances between companies from the drugs and medical devices areas assist them in taking advantage of the existing technologies by avoiding capital expenditure in R&D and take the drug-device combination market to new heights.

What makes our reports unique?

1. We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

2. Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

3. No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.

4. We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

5. 15 pages of high level analysis including benchmarking strategies, best practices and the market?s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

6. Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

1. Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?

2. What are market estimates and forecasts; which markets are doing well and which are not?

3. Where are the gaps and opportunities; what is driving the market?

4. Which are the key playing fields? Which are the winning edge imperatives?

5. How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For more information, please visit :
http://www.aarkstore.com/reports/Drug-and-Device-Combination-2009-2014–16959.html
Or email us at [email protected] or call +919272852585

(Malibu, CA) – March, 2009 – It has come to our attention that a 3rd party has written a Press Release about CliffsideMalibu.com without it’s authorization and in fact, wrongly stating that CliffsideMalibu.com had in fact written this Press Release. Nothing could be further from the truth. Without referring to the specific article but instead, posting our response on all of the websites that the previous article had been posted on we want to assure all past and future clients that no one at CliffsideMalibu.com would ever, in any way, shape or form enter into the practice of disclosing the identities of any of our cliental, no matter what the practice of other facilities claiming to be high end. Our statement is, always has been, and always will be, that we can neither confirm, nor deny, the admittance, past or present of anyone seeking private, confidential treatment at our facility.

It is clear CliffsideMalibu.com takes their client privacy and confidentiality very seriously. The facility is hidden away in a private, very exclusive part of Malibu. Not only is confidentiality of utmost importance due to the sensitivity of the treatment being provided there, but a great deal in fact because the patients that are treated at the center are often times very high profile. The owner, understanding this special need, wants to ensure that all of his patients can comfortably recover knowing that confidentiality is not a concern.

A quick visit to their site shows a client testimonials page, filled with an outpouring of gracious “thank you`s “, all signed with initialed last names or simply “Name Withheld”. Further demonstrating that their client names are always treated with seriousness in confidentiality.

With so many highly recognizable public figures finding themselves in need of addiction or disorder treatment programs, it`s no wonder the media and paparazzi have attempted to publicize and exploit the celebrity in need of such treatment. It`s easy to see such media frenzy has surrounded many of Hollywood`s elite, along with their attending treatment centers. Cliffside has recognized the risk in extending its services to the type of public figures that would bring the media and paparazzi swarming the facility. Not wanting to jeopardize the privacy of the other guests, they have even opted out of treating some high profile celebrities at their center. The guests at Cliffside can rest assured, knowing that the staff cares so much about their recovery they would deny service to high paying, Hollywood elite, before they would endanger the other guests safety and privacy.

I think it takes a special breed to own and operate a drug and alcohol treatment facility. You have to truly care for the people you are treating in order to cultivate a positive and effective environment. The patient’s successful recovery is paramount for the on-going success and reputation of the treatment facility itself. Cliffside`s staff has obviously come from that special breed. With a personalized treatment program guided by philosophy that boasts one-to-one patient/therapist interaction, coupled with the most peaceful and luxurious surroundings one can buy, it`s no wonder high profile public figures and local clients alike choose CliffsideMalibu.com as their treatment center. A great deal of the recovery process involves trust in the providers of that treatment. I am confident that trust has been earned and will continue to be given by all who have visited the Cliffside facilities.

This Press Release was written by Jenny Amato, a volunteer for CliffsideMalibu.com. For more information on the facilities drug rehab and other treatment programs, feel free to contact [email protected] or call 1-800-501-1988.

Contact Details:
Cliffside Malibu
1-800-501-1988
www.cliffsidemalibu.com
[email protected]

08.01.09, California — Finding home away from home is not easy but Axis Residential Treatment Center has made it sound so. It has been learnt from reliable sources that patients who seek physical as well as mental help, support and treatment, have found a dependable home in this rehab.

Talking to the medical staff at Axis Residential Treatment Center revealed that an intensive and extensive training term on medical and psychological treatment had been inculcated in them before starting off with the job. One of the counselors there vouches for this – “we had to undergo six long months of rigorous training as to how the patients with alcohol/drug addiction problem need to be treated, what are their emotional and psychological needs and how patiently the cases need to be dealt with. Later, while dealing with patients, we actually realized that the medication that is required by a drug addict is truly not the only prerequisite but what they seek for most is emotional support. We, at Axis, diligently see to it that they are not only medically recovered but also emotionally strengthened for a drug free future.”

As gathered from one of the inmates of Axis Residential Treatment Center, it is more of a home than a treatment center for them. Mr. Brown, a twenty five year old drug addict who got admitted to this house for rehabilitation six months ago, testifies, “Initially I thought I was being introduced into a life of confinement, a schedule of strict regimen where doctors would be more like taskmasters than physicians. But to my utter amazement, the staffs here are absolute god and goddesses in the shape of doctors. They made me feel at home in the exact sense of the term and treated me like one of their kin. Through an elaborate process of detox, medication and therapies I have almost reached the end of my program. God bless them.”

The statements of the center’s faculty as well as the patients reiterate the notion that Axis Residential Treatment Center is a home and haven for the drug/alcohol addicts. People with addiction problems go there for wellness solutions, physiological and psychological, and receive the best of both worlds.